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lated and examined for expression levels of NF-κB and vis-
fatin mRNA with the real-time polymerase chain reaction 
method. Data were compared between the different groups 
using one-way analysis of variance.  Results: The expression 
level of NF-κB mRNA in the S+HFD group was 2.67, which 
was statistically higher than the levels in the ND (0.96;  p = 
0.001), S+ND (1.86;  p = 0.05), and HFD (1.26;  p = 0.001) groups. 
Also, the visfatin mRNA expression level in the S+HFD group 
was 4.21, which was higher than the levels in the ND (0.92), 
S+ND (1.79), and HFD (2.20) ( p = 0.001) groups.  Conclusion: 
In this study, the expression levels of NF-κB and visfatin were 
markedly higher in the S+HFD group in comparison to the 
other groups. These findings indicate that alternative signal-
ing pathways might be activated in diet-induced obesity as-
sociated with the OVA-sensitized animal model and could be 
responsible for possible altered sensitization phenotype. 
 © 2017 S. Karger AG, Basel 
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 Abstract 
 Objective: To investigate the effects of diet-induced obesity 
on the expression of nuclear factor-κB (NF-κB) and visfatin 
messenger RNA in male Wistar rats’ tracheae after sensitiza-
tion with ovalbumin (OVA).  Materials and Methods: Twenty 
male Wistar rats were divided into 4 groups ( n = 5 for each 
group), which included a control group fed a normal diet 
(ND) and groups fed normal diet, OVA-sensitized (S+ND); 
high-fat diet (HFD) only (diet-induced obesity); and high-fat 
diet, OVA-sensitized (S+HFD). All animals were fed for 8 
weeks with standard chow or a high-fat diet, and then were 
sensitized and challenged with OVA or saline for another 4 
weeks as per the above groups. The rats were anesthetized, 
after which the necks were exposed and the tracheae iso-
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 Significiance of the Study 
 • The present study showed that the expression levels of nuclear factor-κB  (NF-κB) and visfatin mRNAs 
in trachea tissue were markedly higher in diet-induced obesity ovalbumin (OVA)-sensitized rats com-
pared with normal diet OVA-sensitized rats. Equally important, a significant positive correlation was 
observed between NF-κB mRNA expression and weight changes as well as visfatin mRNA. These find-
ings indicate an alternative signaling pathway in the obesity associated with the OVA-sensitized animal 
model, and could be responsible for altered expression levels of adipokines and especially the role of 
visfatin and NF-κB  in tracheal tissue. 
Th is is an Open Access article licensed under the terms of the
Creative Commons Attribution-NonCommercial 3.0 Un-
ported license (CC BY-NC) (www.karger.com/OA-license), 
applicable to the online version of the article only. Distribu-
tion permitted for non-commercial purposes only.
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 Introduction 
 The prevalence of asthma and obesity has been rising 
in recent years and numerous clinical studies have indi-
cated a significant association between obesity and asth-
ma  [1] . Importantly, in the overweight and obese indi-
viduals, studies have shown a decreased response to in-
haled corticosteroids  [2] or long-acting β-agonists  [3] , 
which are the medications commonly used for treating 
asthma. The underlying mechanism(s) for this link is un-
clear, although a number of studies had explored some 
hypotheses, including inflammation, mechanical factors, 
and common genetic determinants  [1, 4] .
 Transcription factor nuclear factor-κB (NF-κB) in-
volved in the pathophysiology of asthma is considered a 
master regulator of inflammatory and immune responses 
 [5, 6] . In various studies, NF-κB has been shown to play a 
critical role in maintaining the chronic inflammatory re-
sponse in asthma  [5, 7] . NF-κB increases in the majority of 
chronic inflammatory conditions such as asthma and ar-
thritis  [7] . However, it has been reported that the effect of 
obesity on lung tissue involved inflammatory changes in 
pulmonary microenvironment  [4] . Many interactions be-
tween the immune system and metabolism appear to be 
mediated by a complex network of soluble mediators se-
creted from immune cells and adipocytes, known as adi-
pokines (also called adipocytokines)  [8] . In this regard, it 
has been reported that adipokines increased airway aller-
gic inflammation and could lead to airway hyperrespon-
siveness  [9, 10] , the main characteristics of bronchial asth-
ma. There is much evidence supporting the important role 
of leptin and adiponectin in inflammatory processes in 
asthma, but only a little has been identified about other 
adipokines such as visfatin  [10] . Visfatin, also known as 
pre-B cell colony-enhancing factor and nicotinamide 
phosphoribosyl transferase, was first discovered in lym-
phocytes, bone marrow, liver, muscle  [11] , and later in 
lungs  [12] . The main sources of visfatin are granulocytes, 
monocytes, macrophages, and adipocytes  [13] . A variety 
of human and animal studies have indicated that visfatin 
is a proinflammatory cytokine and is involved in regulat-
ing inflammation and innate immunity  [14] . Hence, based 
on the above observations, it is proposed that in the obe-
sity associated with asthma, altered expression levels of 
adipokines, with a special focus on the role of visfatin, as 
well as NF-κB mRNA and NF-κB protein levels could im-
pact the asthma phenotype. Therefore, the objective of this 
study was to investigate the effects of a diet-induced obe-
sity on levels of visfatin and NF-κB mRNA in the tracheae 
of male Wistar rats sensitized with ovalbumin (OVA).
 Materials and Methods 
 Animals and Diets 
 Twenty male Wistar rats (8 weeks old, weighing approximate-
ly 160 g) were obtained from Animal House, Tabriz University of 
Medical Science, Tabriz, Iran. All the rats were placed in cages
( n = 5 per cage) under controlled conditions of 22  °  C and a 12- to 
12-h light-dark cycle. Food and water were provided ad libitum 
throughout the acclimatization and experimental period.
 After a week of acclimatization, all the rats were randomly di-
vided into 4 groups ( n = 5 in each group), which included a control 
group fed a normal diet (ND), an OVA-sensitized group with nor-
mal diet (S+ND), high-fat diet group (HFD diet-induced obesity), 
and an OVA-sensitized with high-fat diet group (S+HFD). The 
high-fat diet was to induce obesity as previously described  [15] . 
Briefly, the high-fat diet was fat: 42% energy; protein: 19%; and 
carbohydrate: 39% given to HFD and S+HFD while ND and S+ND 
rats were fed standard rat chow (fat: 11%; protein: 28%; and car-
bohydrate: 61%) (Behparvar Feed Manufacturing Co., Iran).
 After 8 weeks, sensitization of animals with OVA in the S+ND 
and S+HFD groups was performed with the previous protocol  [16] 
and lasted 4 weeks.
 Animal Sensitization 
 Briefly, 1 mg OVA and 200 mg aluminum hydroxide (Sigma) 
were injected intraperitoneally on days 1 and 8. From day 14, the 
animals were placed in a closed chamber (dimensions: 30 × 20 × 
20 cm) exposed to aerosol particles of 4% OVA for 17–19 days, 15 
min daily, using a nebulizer (CX3, Omron Health Care Europe 
B.V., the Netherlands). The rats of the ND and HFD groups were 
treated similarly with saline instead of OVA solution. Rats are eas-
ily sensitized using OVA and show immediate and late sensitiza-
tion responses after an allergen challenge  [17] . The study was ap-
proved by the Ethical Committee of Tabriz University of Medical 
Sciences.
 Body Weight 
 The animals were weighed weekly at approximately 16: 00 dur-
ing the experiment. All rats were anesthetized and weighed, and 
the distance between rats’ nose and anus (nasoanal length) was 
measured. Final body weight, Lee index, and percentage of body 
fat (BF%) were also determined to calculate the obesity indexes 
used in rodents  [18] . Briefly, the following formulae were used to 
calculate all obesity indexes  [18] :
 1.  Percentage of body weight changes (%) = ((Final weight – 
initial weight)/initial weight) × 100 
 2. Lee index (mg/mm) = Final weight 0.33 /naso-anal length. 
 3. Percentage of body fat (%) = 0.69 (Lee index – 274.8). 
 Tissue Preparation 
 The rats were anesthetized with an intraperitoneal injection of 
ketamine (50 mg/kg) and xylazine (5 mg/kg); the chests and necks 
were opened and approximately 2 cm of the trachea was isolated. 
The trachea was divided into several 5-mm segments (5–6 ring 
cartilage) that were immediately placed between 2 horizontal 
hooks of stainless steel suspended in a 20-mL organ bath (Schuler 
Organ Bath Type 809; March-Hugstetten, Germany) containing 
Krebs-Henseleit solution. The initial tension was 1 g throughout 
the experiment and the equilibrium period was 60 min in which, 
the bath solution was replaced every 15 min. Contractility respons-
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es were measured using vernier control type 850N sensor (sensitiv-
ity range: 0–20 g and resolution: 0.2 mm/turn [Hugo-Sachs Elek-
tronik, Germany]) and amplified with an amplifier (ML/118 quad 
bridge amp, March- Hugstetten, Germany) and recorded on pow-
er lab (ML-750,4channel recorder, March-Hugstetten, Germany).
 Assessment of Tracheal Response to Methacholine 
 The contractility response to 1 m M methacholine hydrochlo-
ride (Sigma Chemical Ltd., UK) as the magnitude of contraction 
was measured. At the end of the experiments, the tissue was 
weighed and then the contraction force was induced by methacho-
line (at plateau level) was calculated to express as g force/mg tissue 
weight (gF/TW) for comparing the spasmogenic activity of these 
spasmogens between groups.
 Biochemical Measurements 
 After the rats were anesthetized with ketamine and xylazine, 
blood samples (3–5 mL per rat) were withdrawn from the heart of 
fasted rats into EDTA tubes. Plasma total cholesterol (TC), triglyc-
erides (TG), and high-density lipoprotein-cholesterol (HDL-C) 
concentrations were measured using an automatic blood analyzer 
(Bayer Corp., USA). TGs, TC, and HDL-C kits were obtained from 
Pars Azmoon Co., Iran. Low-density lipoprotein-cholesterol 
(LDL-C) was evaluated using the Friedewald formula: LDL-C = 
TC – (HDL-C + TG/5)  [19] .
 Tissue Sampling and Protein Measurement 
 After withdrawing blood samples, the rats were sacrificed. 
Then tracheal tissues were removed and, after quick freezing with 
nitrogen, all tissues were stored at –70  °  C temperature until NF-κB 
measurement.
 Tissue samples were weighed, the cellular contents were ex-
tracted with the homogenitor (Potter S, Germany) in PBS (pH 7.2–
7.4), and were centrifuged for 20 min at the speed of 3,000 rpm at 
4  °  C. Then supernatants were removed and NF-κB molecules (an-
tigens) were detected by the ELISA method. The  ELISA assays 
were performed using commercial ELISA kits (Hangzhou Eastbio-
pharm Co., Ltd., catalog: BYEK 1184). The absorption was deter-
mined with the microplate absorbance reader at 450 nm. The low-
er detection limit was 2 pg/mL for visfatin (coefficients of varia-
tion; intra-assay: 10%, inter-assay: 12%).
 Real-Time Polymerase Chain Reaction 
 The RNA content and purity were measured using a Nanodrop 
1000 spectrophotometer (Thermo Scientific, Wilmington, DE, 
USA). For determination of NF-κB and visfatin mRNA expression 
levels, the Revert Aid First-Strand cDNA Synthesis Kit (Fermentas 
GmbH, Leon-Rot, Germany) with the aid of random hexamer 
primers and MMLV reverse transcriptase (as a complete system 
for efficient synthesis of first-strand cDNA from mRNA or total 
RNA templates) was used.
 With SYBR Green Master Mix (Exiqon), each cDNA was used 
as a template for separate assays for mRNA quantitative real-time 
PCR. The locked nucleic acid forward and reverse primer sets (Ex-
iqon) for mRNA include: NF-κB1 (sense: 5 ′ -AATTGCCCCG-
GCAT-3 ′ and antisense: 3 ′ -TCCCGTAACCGCGTA-5 ′ 
[XM_342346.4]), visfatin (sense:5 ′ -CCTCTTGAATTGCTCCT-
TCA-3 ′ and antisense: 5 ′ -CCGTATGGAGAAGATCATGG-3 ′ 
[NM_177928]), and β-glucuronidase (sense:5 ′ -GGCTCGG-
GGCAAATT-3 ′ and antisense: 3 ′ -GGGGCAGCACGAT-5 ′ 
[NM_017015.2]). Real-time PCR reactions were performed on a 
Rotor-Gene 6000 instrument (Corbett Life Science, Australia).
 The PCR products were normalized with β-glucuronidase 
genes for mRNA samples. The 2 –(ΔΔ Ct) method was used to deter-
mine relative quantitative levels of NF-κB and visfatin mRNA. Re-
sults were expressed as fold change versus the relevant controls 
 [20] .
 Statistical Analysis 
 All results were given in means ± SD. Data were compared be-
tween different groups using one-way analysis of variance with a 
Tukey-Kramer post hoc  test .  p values <0.05 were considered sig-
nificant. The correlation between NF-κB and visfatin mRNA levels 
and weight was assessed with the Pearson correlation coefficient. 
SPSS 16 software was used for statistical analysis.
 Results 
 The body weight characteristics of the rats are given in 
 Table  1 . The final body weight in HFD (373.60 g) and 
S+HFD (378.60 g) animals were significantly higher than 
ND (327.20 g) and S+ND (323.40 g) animals ( p < 0.001). 
 Table 1.  Weight changes and obesity indexes in the experimental groups
Variables ND S+ND HFD S+HFD
Initial body weight, g 162 ± 3.50 160.00 ± 3.31 161.00 ± 3.31 162.80 ± 6.30
Final body weight, g 327.20 ± 13.84 323.40 ± 13.81 373.60 ± 6.58***, +++ 378.60 ± 16.14***, +++
Percentage of body weight change, % 101.71 ± 7.39 102.07 ± 5.29 132.15 ± 7.05***, +++ 132.60 ± 6.63***, +++
Lee index, mg/mm 307.02 ± 3.35 306.37 ± 2.60 317.55 ± 2.7911***, +++ 318.34 ± 2.31***, +++
Percentage of body fat, % 22.64 ± 2.27 21.77 ± 1.79 29.49 ± 1.54***, +++ 30.04 ± 1.59***, +++
 ND, control with normal diet; S+ND, ovalbumin-sensitized with normal diet; HFD, high-fat diet alone; S+HFD, ovalbumin-sensi-
tized with high-fat diet. Differences between results of ND with those of other groups: *** p < 0.001. Differences between results of the 
S+ND group with those of the HFD and S+HFD groups: +++ p < 0.001. For each group, n = 5.
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Also, the Lee index in HFD (317.55) and S+HFD (318.34) 
groups were enhanced when compared with the ND 
(307.02) and S+ND (306.37) groups ( p < 0.001). More-
over, results showed that BF% in the HFD (29.49%) and 
S+HFD (30.04%) groups was significantly higher than the 
ND (22.64%) and S+ND (21.77%) groups ( p < 0.001). 
However, there were no significant differences in final 
body weight, Lee index, and BF% between the ND and 
S+ND groups, or HFD and S+HFD groups.
 The lipid profiles of TC, TG, HDL-C, and LDL-C in 
the diet-induced obesity groups (HFD and S+HFD) are 
shown in  Figure 1 a and they were significantly higher 
than the non-diet-induced obesity groups ( p < 0.05 to  p < 
0.001). There were no significant differences in the lipid 
profile test among the normal diet control groups (ND vs. 
S+ND) and the diet-induced obesity groups (HFD vs. 
S+HFD).
 Pearson correlation analyses of lipid profile and NF-
κB, visfatin mRNA, and NF-κB protein are shown in 
 Table 2 . There were significant positive correlations be-
tween NF-κB mRNA with TC ( r = 0.466), HDL ( r = 
0.442), and TG ( r = 0.597). Also, there was borderline 
correlation ( r = 0.388) between visfatin mRNA and 
LDL, and significant correlations with other lipid pro-
files.
 Trachea Response to Methacholine 
 The contractility results obtained from gF/TW shows 
that gF/TW in S+HFD (36.60 ± 0.95) animals was sig-
nificantly higher than other groups ( p < 0.01 to  p < 0.001, 
 Fig. 1 b). Also, gF/TW in S+ND (28.43 ± 4.01) animals was 
significantly higher than those in the ND and HFD groups 
( p < 0.01). There was no significant difference in gF/TW 
between the ND and HFD animals.
 Visfatin mRNA Expression Level in Tracheal Tissue 
 Visfatin mRNA expression in the ND group (0.92 ± 
0.25) was significantly lower than the S+ND (1.79 ± 0.32, 
 p < 0.05), HFD (2.22 ± 0.6,  p < 0.01), and S+HFD (4.21 ± 
0.39,  p < 0.001) groups. Also, visfatin mRNA expression 
in the S+HFD group increased significantly compared 
with the HFD and S+ND groups ( p < 0.001). Although 
mean visfatin mRNA expression was higher in the HFD 
group (2.22 ± 0.60) compared with the S+ND group (1.79 
± 0.32), the difference was not statistically significant
( p = 0.376) ( Fig. 2 a).
 There was a significant positive correlation between 
visfatin mRNA expression and final body weight ( r = 
0.716), percentage of weight changes ( r = 0.710), Lee in-
dex ( r = 0.708), and BF% ( r = 0.689) ( Table 2 ).
 NF-κB mRNA Expression Level in Tracheal Tissue 
 The NF-κB  mRNA expression in rat tracheal tissue is 
presented in  Figure 2 b. The OVA sensitization in the 
S+ND group caused a significant increase in NF-κB 
mRNA expression (1.86 ± 0.20) when compared with 
the ND group (0.96 ± 0.13,  p < 0.01), and was borderline 
significantly higher than HFD (1.26 ± 0.22,  p = 0.09). 
On the other hand, after diet-induced obesity and OVA 
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tistical differences between the ND and other groups:  *   p < 0.05; 
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sensitization, the amount of NF-κB mRNA expression 
levels were significantly higher in the S+HFD group 
(2.63 ± 0.67) than in the other groups, especially the 
S+ND group (1.86 ± 0.20) ( p < 0.05 to  p < 0.001). There 
was no significant difference between the ND and HFD 
groups.
 A significant positive correlation was found between 
NF-κB mRNA expression and percentage of weight 
changes ( r = 0.453,  p < 0.05;  Table 2 ). This correlation was 
not significant with final body weight and other obesity 
indexes, Lee index, and BF%. Further, there was a marked 
positive correlation between NF-κB mRNA expression 
and visfatin mRNA expression level in tracheal tissue
( r = 0.778,  p < 0.001;  Fig. 2 d).
 NF-κB Protein in Tracheal Tissue 
 The NF-κB protein level in OVA-sensitized groups 
(S+ND and S+HFD) was significantly higher compared 
to the control groups ( p < 0.05 to  p < 0.001;  Fig. 2 c). Al-
though mean NF-κB protein was higher in the S+HFD 
group (66.57 ± 7.14) compared with the S+ND group 
(60.78 ± 6.70), the difference was not significant ( p = 
0.403). Also, there was no significant ( p = 0.962) differ-
ence between ND and HFD.
 There was no significant correlation between NF-κB 
protein and obesity indexes (percentage of weight chang-
es, Lee index, BF%, and final body weight) ( Table 2 ). Ad-
ditionally, there was a marked positive correlation be-
tween NF-κB protein level and visfatin mRNA expression 
level in tracheal tissue ( r = 0.675,  p < 0.001;  Fig. 2 e).
 Discussion 
 In this study, diet-induced obesity caused high body 
weight and obesity indices in rats (percentage of weight 
changes, Lee index, and fat percent) similar to the previ-
ous study  [15] . Also, in diet-induced obesity, lipid profiles 
(total cholesterol, triglyceride, HDL-C and LDL-C) were 
significantly higher in obese groups than other groups.
 Airway contractility to methacholine was higher in 
sensitized lean and diet-induced obesity rats compared 
with nonsensitized controls. The airway contractility to 
methacholine was highest in the diet-induced obesity 
sensitized rats. Airway hyperresponsiveness, bronchoal-
veolar lavage fluid eosinophilia, and smooth muscle hy-
pertrophy are some characteristics of asthma. In our pres-
ent study, OVA sensitization showed airway hyperre-
sponsiveness in an animal model and  confirmed previous 
reports of bronchial hyperreactivity development in 
obese rats  [21] .
 The results of the present study showed that the ex-
pression level of visfatin significantly increased in obese 
OVA-sensitized rats. Fat tissue is considered as an endo-
crine organ which indicates increased inflammatory ac-
tivity. Mouse models of obesity and asthma have illumi-
nated the possible role of leptin, adiponectin, and other 
inflammatory mediators in the association between obe-
sity and asthma  [1] . Moreover, the results showed that 
there was a positive correlation between serum lipid pro-
file and expression level of visfatin mRNA, and also be-
tween weight gain and visfatin expression in the trachea 
in the OVA-sensitization condition. Additionally, we 
found a marked positive correlation between visfatin 
 Table 2.  Pearson correlation analysis of parameters of study with NF-κβ mRNA, visfatin mRNA, and NF-κβ pro-
tein levels in trachea tissue
Parameters NF-κβ mRNA Visfatin mRNA  NF-κβ protein
r p r p r p
Cholesterol 0.466 0.038 0.734 0.000 0.301 0.198
Triglyceride 0.595 0.006 0.787 0.000 0.447 0.048
HDL 0.442 0.051 0.776 0.000 0.301 0.198
LDL 0.295 0.207 0.388 0.091 0.143 0.548
Final body weight 0.395 0.085 0.716 0.000 0.306 0.190
Percentage of body weight change 0.453 0.045 0.710 0.000 0.345 0.136
Lee index 0.370 0.108 0.708 0.000 0.301 0.197
Percentage of body fat 0.354 0.126 0.689 0.001 0.297 0.203
 HDL, high-density lipoprotein; LDL, low-density lipoprotein.
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mRNA expression and NF-κB mRNA and protein levels 
in the trachea. It has been shown that the activity of pro-
inflammatory functions wase exerted by visfatin  [22] . 
Visfatin upregulates the production of IL-1β, IL-6, IL-10, 
and TNF-α in human monocytes  [22] in an extracellular 
cytokine manner through the NF-κB activation pathway. 
Furthermore, visfatin is able to inhibit apoptosis in neu-
trophils and lead to perpetuation of inflammation  [23] . It 
is believed that visfatin acts as a potent chemotactic fac-
tor, especially for recruitment of monocytes  [24] . Local 
inflammation in arthrosclerosis plaque has the main role 
in the pathogenesis of coronary arterial disease and sys-
temic inflammation is thought to interact with this pro-
cess  [25] . Perhaps a similar theory is also associated in the 
obese asthmatic conditions.
 OVA sensitization in rats led to overexpression of NF-
κB mRNA in tracheal tissue. Surprisingly, after diet-in-
duced obesity in the OVA-sensitized group, the NF-κB 
mRNA expression level was markedly higher compared 
to the lean OVA-sensitized group. Further results of this 
study showed that there was a positive correlation be-
tween the serum lipid profile and expression level of NF-
κB mRNA, as well as between weight gain and NF-κB 
expression in the trachea in the rat OVA-sensitization 
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tracheal tissue. Values are depicted as means ± SD. ND, control 
with normal diet; S+ND, ovalbumin-sensitized with normal diet; 
HFD, high-fat diet; S+HFD, ovalbumin-sensitized with high-fat 
diet. Statistical differences between ND and other groups:  *    p < 
0.05;  * *    p < 0.01;  * * *    p < 0.001. Statistical differences between 
S+ND and HFD groups:  +   p < 0.05;  +++   p < 0.001. Difference be-
tween HFD and S+HFD:  ##   p < 0.01;  ###  p < 0.001. For each group, 
 n = 5. 
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condition. The authors did not rule out the effect of lipid 
profile changes on cellular signal pathways. It has been 
shown that free fatty acids are able to activate inflamma-
tory pathways in tissues  [26] . Elevated NF-κB in this 
study model may be the result of an increased lipid pro-
file, which need further study. Also, in an effort to further 
understand the role of NF-κB in the relationship between 
obesity and asthma, the NF-κB protein level in the trachea 
was tested in this study. The results indicated that the pro-
tein level of NF-κB increased in the OVA-sensitization 
state, with a greater increase in diet-induced obesity 
OVA-sensitized rats.
 Obesity is a low-grade chronic proinflammatory state, 
identified by enhances in serum levels of various chemo-
kines, cytokines, and soluble cytokine receptors, and re-
sults in airway inflammation and asthma severity  [27] . 
Previous reports have indicated that NF-κB has an im-
portant role in allergic inflammation of airways  [28] . A 
study conducted by Poynter et al.  [5] showed that rapid 
and selective activation of NF-κB occurred in mice airway 
epithelium challenged and sensitized with antigen. Ad-
ditionally, inhibition of NF-κB activity in these cells re-
duced the inflammatory response to antigen challenge 
 [29] . In animal models of allergen-mediated airway in-
flammation and in patients with asthma, NF-κB activity 
has been demonstrated in lung tissue, particularly in air-
way epithelial  [30] . From the results of this study, it can 
be inferred that increased expression and protein levels of 
NF-κB in the trachea, as well as increased levels of circu-
lating cytokines in this condition, can synergistically im-
pact airway inflammation and may lead to deterioration 
of sensitization. But it should be kept in mind that mea-
surement of p65 of NF-κB is a better way to show the ac-
tivity of NF-κB which needs to be further studies.
 Increased expression level of visfatin mRNA, as well as 
increased NF-κB expression in trachea tissue in the OVA-
sensitization condition can, at least in part, indicate an 
altered signaling pathway in the obesity condition. En-
hanced adipokines in the trachea may change the airway 
responsiveness in obese allergic airway inflammation. 
The findings of the current study, such as upregulation of 
visfatin and NF-κB in diet-induced obesity sensitized 
with OVA condition in animal model support the hy-
pothesis that not only systemic but also local inflamma-
tion may be involved in pathophysiologic changes in obe-
sity-associated allergic airway inflammation.
 Conclusion 
 Diet-induced obesity caused a high expression of NF-
κB and visfatin mRNA as well as NF-κB protein levels in 
the tracheae of male OVA-sensitized rats. NF-κB has an 
important role in allergic airway inflammation. In obe-
sity associated with the OVA-sensitization condition, el-
evated NF-kB mRNA and protein levels in trachea tissue 
indicate that cell-signaling pathways are increasing in-
flammatory status. There is also a significant correlation 
between visfatin and NF-kB in trachea tissue, suggesting 
a local inflammatory change in tissue, independent (or 
dependent) of possible systemic changes in obesity asso-
ciated with OVA-sensitization conditions.
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